跳转至内容
Merck

SML0031

Sigma-Aldrich

DBeQ

≥98% (HPLC)

别名:

JRF 12, N2,N4-二苄基喹唑啉-2,4-二胺

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C22H20N4
分子量:
340.42
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: ≥20 mg/mL

儲存溫度

room temp

SMILES 字串

C(Nc1nc(NCc2ccccc2)c3ccccc3n1)c4ccccc4

InChI

1S/C22H20N4/c1-3-9-17(10-4-1)15-23-21-19-13-7-8-14-20(19)25-22(26-21)24-16-18-11-5-2-6-12-18/h1-14H,15-16H2,(H2,23,24,25,26)

InChI 密鑰

QAIMUUJJAJBPCL-UHFFFAOYSA-N

應用

用DBeQ处理HeLa细胞,并通过活细胞成像对该处理对细胞 体内 泛素化和蛋白质脱位的影响进行了研究。

生化/生理作用

DBeQ是ATP酶p97的有效和特异性抑制剂,ATP酶是泛素-融合降解(UFD)途径的组成部分。DBeQ可抑制泛素化蛋白质的降解、内质网相关的降解途径、以及自噬体成熟。该化合物还可有效抑制细胞增殖并诱导胱天蛋白酶3/7的活性和细胞凋亡。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Holger W Auner et al.
PloS one, 8(9), e74415-e74415 (2013-09-27)
Inhibition of the proteasome is a widely used strategy for treating multiple myeloma that takes advantage of the heavy secretory load that multiple myeloma cells (MMCs) have to deal with. Resistance of MMCs to proteasome inhibition has been linked to
Ajit Tiwari et al.
Scientific reports, 6, 38681-38681 (2016-12-09)
Caveolin-1 (Cav1) drives the formation of flask-shaped membrane invaginations known as caveolae that participate in signaling, clathrin-independent endocytosis and mechanotransduction. Overexpression or mutations of Cav1 can lead to its mistrafficking, including its accumulation in a perinuclear compartment previously identified as
Ainoa Figuerola-Conchas et al.
ACS chemical biology, 15(1), 243-253 (2019-12-04)
VCP/p97 belongs to the AAA+ ATPase family and has an essential role in several cellular processes ranging from cell division to protein homeostasis. Compounds targeting p97 inhibit the main ATPase domain and cause cell death. Here, using PNA-encoded chemical libraries
Sandra Loaiza et al.
Biomaterials, 183, 102-113 (2018-08-29)
Cellular function depends on the maintenance of protein homeostasis (proteostasis) by regulated protein degradation. Chronic dysregulation of proteostasis is associated with neurodegenerative and age-related diseases, and drugs targeting components of the protein degradation apparatus are increasingly used in cancer therapies.
Aparna Shinde et al.
Cancer research, 79(8), 1831-1843 (2019-02-09)
The ability of breast cancer cells to transiently transition between epithelial and mesenchymal states contributes to their metastatic potential. Therefore, driving tumor cells into a stable mesenchymal state, as opposed to complete tumor cell eradication, presents an opportunity to pharmacologically

商品

We presents an article on Autophagy in Cancer Promotes Therapeutic Resistance

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门